A new study linked a hidden RNA modification to ferroptosis escape and chemotherapy resistance in pancreatic cancer, identifying a mechanism that helps tumors withstand gemcitabine exposure. The work, published in Nature Cancer, positions the modification as a potential target for sensitization strategies. For pancreatic oncology, the update adds another layer to the resistance map beyond dense tumor architecture and hypoxia, reinforcing that RNA-level regulatory control can drive treatment failure. It may shape future combination development aimed at restoring vulnerability to ferroptotic cell death.